Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly ...

Many people worry that passing gallstones is linked to an increased risk of bile duct cancer due to inflammation and ...

Obeticholic acid was given accelerated approval by the FDA in May 2016 as a second-line treatment for PBC patients not ...

Cholangiocarcinoma is classically described as an irregular narrowing of the bile duct with shouldered scalloped margins. The stricture usually causes a high-grade or complete obstruction with ...

Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is advanced, ...

Your GP should arrange for you to see a specialist or have tests if you have symptoms that could be due to bile duct cancer. Depending on your symptoms and other factors, this might be an urgent ...

Even after the diagnosis Ms Edwards said her mother was told her procedure was a routine one with very rare issues ...

Background: The purpose of the present study was to define the differential diagnostic markers of benign and malignant bile duct strictures without demonstrable mass on ultrasonography (US ...

Annexuzlimab is under clinical development by MedAnnex and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to GlobalData, Phase I drugs for Bile Duct Cancer ...

What are congenital liver defects? Congenital liver defects are liver disorders that are present at birth. They are rare. These liver disorders usually block the bile ducts. This affects the flow of ...